Coverage
-
July 31, 2012
Gene sequencing company Illumina Inc. and one of its shareholders agreed Monday to resolve the investor's suit, which he had intended to use as an antidote to Illumina's poison pill efforts to block Roche Holding AG's hostile takeover attempt.
1 other articles on this case.
View all »